MODEL OF OPTIMAL MANUFACTURING OF PHARMACEUTICAL PRODUCTS

Article Sidebar

View in the full issue
Number of views 4

Issue
No. 48 (2021): 8th ISPC «Challenges in Science of Nowadays» (April 4-5, 2021; Washington, USA).
Section
Modeling and Nanotechnology
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Published: Apr 28, 2022

Main Article Content

Dilnoz Muhamediyeva
National Research University «Tashkent Institute of Irrigation and Agricultural Mechanization Engineers»
Mirjalol Norkobilov
National University of the Republic of Uzbekistan

Article Details


How to Cite
Muhamediyeva, D., & Norkobilov, M. (2022). MODEL OF OPTIMAL MANUFACTURING OF PHARMACEUTICAL PRODUCTS. Scientific Collection «InterConf», (48), 432–434. Retrieved from https://archive.interconf.center/index.php/conference-proceeding/article/view/194

References

Artificial intelligence: next frontier for connected pharma. Scalable Health. June 2017. https://www.scalablehealth.com/ai

Thomas Sullivan. A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate for Drugs Entering Clinical Development is Less Than 12%. policymed.com/2014/12/atough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-enteringclinical-

de.html Mar 21, 2019

Most read articles by the same author(s)